XML 72 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
FAIR VALUE DISCLOSURES OF FINANCIAL ASSETS AND LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Carried at Fair Value
The following tables present financial instruments carried at fair value as of December 31, 2024 and December 31, 2023 by level in the valuation hierarchy (as described above):
 
December 31, 2024
(Dollars in thousands)
Quoted Prices in Active Markets
for Identical Asset (Level 1)
Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Total Fair
Value
Assets measured at fair value on a recurring basis:
Available-for-sale securities:
CMO$— $430,942 $— $430,942 
FNMA MBS— 2,755,579 — 2,755,579 
FHLMC MBS— 105,514 — 105,514 
GNMA MBS— 40,676 — 40,676 
GSE agency notes— 177,937 — 177,937 
Other assets— 170,464 25 170,489 
Total assets measured at fair value on a recurring basis$— $3,681,112 $25 $3,681,137 
Liabilities measured at fair value on a recurring basis:
Other liabilities$— $155,242 $5,270 $160,512 
Assets measured at fair value on a nonrecurring basis:
Other investments$— $— $15,516 $15,516 
Other real estate owned— — 5,204 5,204 
Loans held for sale— 49,699 — 49,699 
Total assets measured at fair value on a nonrecurring basis$— $49,699 $20,720 $70,419 
December 31, 2023
(Dollars in thousands)Quoted Prices in Active Markets
for Identical Asset (Level 1)		Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total Fair
Value
Assets measured at fair value on a recurring basis:
Available-for-sale securities:
CMO$— $464,619 $— $464,619 
FNMA MBS— 3,042,350 — 3,042,350 
FHLMC MBS— 115,532 — 115,532 
GNMA MBS— 43,340 — 43,340 
GSE agency notes— 180,696 — 180,696 
Other assets— 153,569 78 153,647 
Total assets measured at fair value on a recurring basis$— $4,000,106 $78 $4,000,184 
Liabilities measured at fair value on a recurring basis:
Other liabilities$— $137,616 $14,026 $151,642 
Assets measured at fair value on a nonrecurring basis:
Other investments$— $— $15,206 $15,206 
Other real estate owned— — 1,569 1,569 
Loans held for sale— 29,268 — 29,268 
Total assets measured at fair value on a nonrecurring basis$— $29,268 $16,775 $46,043 
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The following table provides a description of the valuation techniques and significant unobservable inputs for the Company's financial instruments classified as Level 3 as of December 31, 2024 and December 31, 2023:
(Dollars in thousands)December 31, 2024
Financial InstrumentFair ValueValuation Technique(s)Unobservable InputRange (Weighted Average)
Other investments$15,516 Observed market comparable transactionsPeriod of observed transactions
December 2023
Other real estate owned5,204 Fair market value of collateralCosts to sell
10.0%
Other assets (Risk participation agreements purchased)25 Credit Value AdjustmentCDS Spread and Loss Given Default (LGD)
CDS spread: 110 - 360 bps (192 bps)
LGD: —% - 30% (30%)
Other liabilities (Risk participation agreements sold)90 Credit Value AdjustmentCDS Spread and Loss Given Default (LGD)
CDS spread: 1 - 250 bps (207 bps)
LGD: 30%
Other liabilities (Financial derivative related to sales of certain Visa Class B shares)5,180 Discounted cash flowTiming of Visa litigation resolution
2.50 years or 2Q 2027
(Dollars in thousands)December 31, 2023
Financial InstrumentFair ValueValuation Technique(s)Unobservable InputRange
(Weighted Average)
Other investments$15,206 Observed market comparable transactionsPeriod of observed transactionsDecember 2023
Other real estate owned1,569 Fair market value of collateralCosts to sell
10.0% - 20.0% (18.1%)
Other assets (Risk participation agreements purchased)78
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 110 - 360 bps (195 bps)
LGD: –% - 30% (30%)
Other liabilities (Risk participation agreements sold)3 
Credit Value Adjustment
CDS Spread and Loss Given Default (LGD)
CDS spread: 1 - 250 bps (95 bps)
LGD: 30%
Other liabilities (Financial derivative related to
sales of certain Visa Class B shares)		14,023 Discounted cash flowTiming of Visa litigation resolution
1.00 - 4.75 years (3.06 years or 4Q 2025)
Schedule of Book Value and Estimated Fair Value of Financial Instruments
The book value and estimated fair value of the Company's financial instruments are as follows:
 
December 31,
Fair Value
Measurement
20242023
(Dollars in thousands)Book ValueFair ValueBook ValueFair Value
Financial assets:
Cash, cash equivalents and restricted cashLevel 1$1,154,818 $1,154,818 $1,092,900 $1,092,900 
Investment securities, available for saleLevel 23,510,648 3,510,648 3,846,537 3,846,537 
Investment securities, held to maturity, netLevel 21,015,161 895,511 1,058,557 985,931 
Other investmentsLevel 318,184 18,184 17,434 17,434 
Loans, held for saleLevel 249,699 49,699 29,268 29,268 
Loans and leases, net(1)
Level 312,996,218 13,100,492 12,583,202 12,514,431 
Stock in FHLB of PittsburghLevel 211,805 11,805 15,398 15,398 
Accrued interest receivableLevel 284,671 84,671 85,979 85,979 
Other assetsLevels 2, 3170,489 170,489 153,647 153,647 
Financial liabilities:
DepositsLevel 2$17,029,808 $17,016,839 $16,474,086 $16,449,198 
Borrowed fundsLevel 2383,607 379,154 895,076 912,760 
Standby letters of creditLevel 3776 776 814 814 
Accrued interest payableLevel 238,173 38,173 46,684 46,684 
Other liabilitiesLevels 2, 3160,512 160,512 151,642 151,642 
(1)Includes reverse mortgage loans.